The New Year has been unsealed, and a joyful annual meeting ignites new efforts.

On January 18, 2025, the 2025 Spring Festival Annual Meeting of Livzon Group, themed "AI Empowerment, Leading Livzon with Intelligence," was brilliantly staged at the Zhuhai International Convention and Exhibition Center. From the theme words to visual expression, from process setup to micro-site information inquiry, from beautiful decoration to artistic programs, the annual meeting integrated AI applications into all aspects, presenting a unique brilliance of "AI empowerment."

At the beginning of the annual meeting, Group Chairman Zhu Baoguo summarized the achievements and challenges of 2024 in his speech, affirming everyone's spirit of daring to strive and face difficulties, and proposed new requirements for the company's operations in the new year. The era of AI has arrived, and biopharmaceutical research and development, as one of the high-precision technologies, must undoubtedly become the protagonist of AI empowerment, making AI our work partner. Chairman Zhu called on everyone to actively embrace the era, embrace AI, improve efficiency and quality, and only by keeping pace with the times can we avoid being eliminated by the era and have a new future.

Looking back at 2024, Livzon Group, with independent innovation as its foundation and BD as its brush, continuously expands its R&D pipeline, achieving commendable results; looking forward to the new year, Livzon Group will focus on "innovative drugs + high-barrier complex formulations" under the dual drive of independent R&D + BD, continuously focusing on unmet clinical needs, expanding the product line in advantageous areas, and exploring new accessibility areas, striving to run at the forefront of R&D innovation.

The injectable acetic acid secukinumab has been approved by the US FDA for market launch, and the injectable acetic acid triptorelin microspheres (1M) for the new indication of endometriosis has been approved for market launch. Nearly 10 varieties, including semaglutide injection for weight loss indications, JP-1366 tablets, and recombinant FSH, have successively entered different stages of clinical trials, showcasing Livzon Group's remarkable achievements in independent R&D; BD continues to make efforts, introducing new recombinant protein influenza vaccines, innovative drugs for PDE-5 inhibitors in the field of urology such as udenafil, innovative drugs for KCNQ2/3 activators in the neuropsychiatric field such as NS-041, and innovative drugs for small nucleic acids (siRNA) in the metabolic field, further expanding Livzon Group's innovation pipeline.

R&D innovation has been frequently reported, marketing is working tirelessly, and production quality is meticulous. Marketing has built a digital marketing system that combines online and offline through deep embrace of the mobile internet, and the use of new media such as expert discussions allows academic promotion to resonate with the times. Production quality is the lifeline of the company's development, and cost reduction and efficiency improvement have successfully achieved the set goals.

As humanity has developed to this day, technology has undergone countless iterations, each leap changing human life. Safeguarding health is the beautiful melody of technological iteration, from the discovery and improvement of a molecule to alleviating suffering. Livzon people are unwaveringly running on the path of innovation. The promotional video and theme of the annual meeting sounded the call for Livzon people to embrace AI, presenting an upward mentality of dancing with the times.

At the annual meeting, individuals and teams that performed outstandingly in the past year were recognized and encouraged. Innovation requires excellent talent, and talent is the most valuable asset. Livzon Group advocates the core values of "people-oriented, craftsmanship spirit, trustworthy, pragmatic, happy life, and joyful work," providing employees with multiple channels for career development, continuously enhancing employees' sense of happiness and achievement, and allowing outstanding talents to continue contributing to the company's development.

After the awards, a stunning and cool light show opened the joyful curtain of the annual meeting. The "Light of Science and Technology, Melody of Patriotism" from Livzon Pharmaceutical Factory is youthful and passionate; the "AI-Shining WE Come" from the marketing headquarters showcases AI empowerment and continuous achievements; the "APT Joyful Youth" from the animal health department is cute and caring for health; the "Auspicious Lion Dance" from Limin Pharmaceutical Factory is joyful and festive; the "Welcoming Spring" from Livzon Reagents is vibrant and striving forward; the "Sense of the Times" from Livzon Synthesis resides in AI, where youth knows no bounds. The carefully arranged artistic programs from various units filled everyone's faces with joy.

As the melody of "Youth" approaches the end of the annual meeting: "I am still the same youth, without a trace of change..." Yes, we are still young, and we should pursue excellence on the path of innovation with the enterprising spirit and fighting spirit of youth.

Driven by passion, we forge ahead;
Shouldering responsibilities, we ride the wind and waves.
In 2025, let us join hands, empowered by AI, and strive for a new year of new surges, working hard for the mission of "putting patient quality of life first."
In 2025, let us empower with AI, lead Livzon with intelligence, and strive for new achievements in the new year of innovation, working hard for the vision of "becoming a leader in the pharmaceutical industry."